Lysosomal Storage Disorders

• Drugs for Pompe Disease - Jun 06, 2024
• Fabry Disease Scan - Apr 07, 2022
• Drugs for Pompe Disease - Feb 03, 2022

• Drugs for Gaucher Disease - Nov 21, 2019
• Fabry Disease - Sep 26, 2019

Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the Non-Preferred Drugs in Select PDL Classes prior authorization criteria. New drugs will be listed as N until reviewed by the P&T Committee and are subject to the New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.